![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
Austria’s Andritz eyes growth in 2025 with ~$9 bn revenue boost
Andritz has forecasted stable revenue and profitability for FY25, with revenue projected between €8.0 billion and €8.3 billion (~$8.72 billion-$9.05 billion). In FY24, revenue fell 4 per cent YoY to €8.31 billion, while order intake declined 3.2 per cent. Net income reached €496.5 million (~$541.19 million), down 1.5 per cent. Q4 order intake rose 24 per cent, while net income declined 3 per cent.
Andritz has forecasted stable revenue and profitability for FY25, with revenue projected between €8.0 billion and €8.3 billion (~$8.72 billion-$9.05 billion).
In FY24, revenue fell 4 per cent YoY to €8.31 billion, while order intake declined 3.2 per cent.
Net income reached €496.5 million (~$541.19 million), down 1.5 per cent.
Q4 order intake rose 24 per cent, while net income declined 3 per cent.
